Clinical Trial Update: Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45). [NA]

View source ↗

Summary

A validation study evaluating whether assessing the subhippocampal region with florbetapir PET can contribute to early detection of Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AMYVID (Florbetapir F-18)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Alzheimer's Disease | NA | Status: UNKNOWN